Back

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism: D-Dimer inter-assay concordance

25 August 2018 (12:35 - 13:25)
Organised by:
Congress Presentation Part of: Venous thrombosis and anticoagulation Venous Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Faizan Khan

The Ottawa Hospital, Ottawa (Canada)

6 More presentations in this session

Presentation thumbnail
Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial
Doctor A. KALAYCI (Boston, US)
Abstract Slides
Presentation thumbnail
Sex differences in the clinical characteristics and outcomes of patients with venous thromboembolism: from the COMMAND VTE Registry
Doctor Y. Yoshikawa (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Short-term versus indefinite anticoagulant therapy for secondary prevention of unprovoked venous thromboembolism: a decision analysis
Mr F. Khan (Ottawa, CA)
Abstract Slides
Presentation thumbnail
Prognostic impact of non-compliance with guidelines-recommended treatment of acute pulmonary embolism: Results of a prospective multicenter registry
Professor N. Meneveau (Besancon, FR)
Abstract Slides
Presentation thumbnail
Evaluation of VTE-BLEED for predicting intracranial or fatal bleedings in stable anticoagulated patients with venous thromboembolism
Doctor E. Klok (Leiden, NL)
Abstract

Access the full session

Session thumbnail
Venous thrombosis and anticoagulation

The Event

Event poster

ESC Congress 2018

25 August 2018 12:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources